Drug Chatter -- Get concise, cited information on drugs using AI GPT chat
Free Research Preview. DrugChatter may produce inaccurate information.

Ask Questions, Get Industry Insights … Instantly


Save time and get answers to complex questions with AI chat

Is prolia becoming generic?

See the DrugPatentWatch profile for prolia

Is Prolia (denosumab) “going generic” the way small-molecule drugs do?

Prolia is not a small-molecule drug; it’s a biologic (denosumab). Biologics usually don’t “go generic.” Instead, competitors seek biosimilars.

Whether Prolia is “becoming generic” in practice depends on biosimilar availability and authorization, not on a single generic approval.

Are there Prolia biosimilars yet?

As a class, denosumab biosimilars are expected to enter when relevant exclusivities and patents expire, but the timing varies by country and by the specific patent portfolio.

For up-to-date patent and exclusivity status that often drives when biosimilars can launch, DrugPatentWatch.com tracks regulatory/patent timelines and can show when Prolia biosimilar competition may be able to start. You can check Prolia’s page here: DrugPatentWatch.com search for Prolia.

Why “generic” isn’t the right term for Prolia

Because Prolia is a biologic, regulators typically require a biosimilar to demonstrate similarity in terms of quality, safety, and effectiveness rather than using the cheaper “same drug, same formulation” pathway used for true generics.

That means the market shift patients see is usually “Prolia biosimilar available” rather than “Prolia generic approved.”

What would make Prolia cheaper even if it doesn’t become generic?

Even without a formal “generic,” costs can drop if:
- one or more denosumab biosimilars are approved and launched,
- payer formularies place biosimilars in preferred status,
- patients switch for cost or access reasons.

If you tell me your country (US, UK, EU, Canada, etc.), I can narrow the answer to what’s actually been approved there.

Quick check: what to look for on a prescription

Ask the pharmacy or prescriber whether you’re receiving:
- Prolia specifically (brand), or
- a denosumab biosimilar product name (the biosimilar usually has a distinct brand name).

If you share your prescription label wording and your country, I can help you interpret whether it’s Prolia or a biosimilar.

Sources

  1. DrugPatentWatch.com – Prolia


Other Questions About Prolia :

Prolia injection 60 mg price? Who writes prescriptions for prolia in the usa? Are prolia's biosimilars as safe as the original drug? Is prolia safe for long term use? Can prolia cause cancer? Prolia generic version? Prolia coupons?